S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseases

Journal of Translational Autoimmunity - Tập 4 - Trang 100093 - 2021
Fanny Duguet1, Céline Ortega-Ferreira2, Benjamin Fould2, Hélène Darville2, Sylvie Berger2, Agnès Chomel2, Grégory Leclerc2, Kai Kisand3,4, Liis Haljasmägi3, Adrian C. Hayday4,5, Emiko Desvaux1, Emmanuel Nony2, Philippe Moingeon1, Frédéric De Ceuninck1
1Center for Therapeutic Innovation, Immuno-inflammatory Disease, Institut de Recherches Servier, 125 Chemin de Ronde, 78290, Croissy sur Seine, France
2Center of Biotechnological Expertise, Institut de Recherches Servier, 125 Chemin de Ronde, 78290, Croissy sur Seine, France
3Molecular Pathology, Institute of Biomedicine and Translational Medicine, University of Tartu, Ravila 19, Tartu, 50411, Estonia
4ImmunoQure AG, Königsallee 90, 2012, Düsseldorf, Germany
5Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King’s College London, The Francis Crick Institute, London, UK

Thông tin
Thông tin xuất bản

Journal of Translational Autoimmunity

Tập 4

100093

Thông tin tác giả